Neurology Minute

Dr. Mona Sazgar discusses tips for treating women with catamenial epilepsy in the second of a three-part series. To learn more, read the article "Treatment of Women with Epilepsy" by Dr. Sazgar in the April 2019 Epilepsy issue of Continuum.

Dr. Mona Sazgar discusses tips for treating women with epilepsy in the first of a three-part series. To learn more, read the article "Treatment of Women with Epilepsy" by Dr. Sazgar in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan Pulst discusses approaches to diagnosing genetic ataxias. 

Dr. Brian Callaghan talks about the rise in out-of-pocket costs for commonly prescribed neurologic medications. 

Dr. Derek Bauer discusses how to optimize epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Derek Bauer offers tips for epilepsy neurologists with more experience in optimizing epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Derek Bauer discusses optimizing management of medically responsive epilepsy. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan U. Schuele offers important takeaways in evaluating seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Stacey Clardy discusses discusses takeaways from Dr. Annie Lannuzel's paper on the long-term outcomes of NeuroZika. 

Dr. Stuart Connolly discusses the main takeaways from his NEJM paper on andexanet alfa for Bleeding Associated with Factor Xa Inhibitors. Read the paper in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051. 

Dr. Jason Crowell discusses the importance of talking to legislators about PCORI. Share your story on the AAN Advocacy Action Center at https://www.aan.com/policy-and-guidelines/advocacy/aan-advocacy-action-center/. 

Dr. Stephan U. Schuele discusses the evaluation of seizure etiology for neurologists with more experience. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan U. Schuele discusses the evaluation of seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Ivan Sanchez Fernandez discusses the main points from his paper on meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.

Dr. Anthony Fauci discusses the main points on his paper on measles in 2019. "Measles in 2019--Going Backward" can be found in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMp1905099. 

Dr. Jason Crowell discusses STEP therapy and recent advocacy efforts by the AAN at Neurology on the Hill. Read the AAN Capitol Hill Report from April 22nd for more: https://www.aan.com/policy-and-guidelines/advocacy/capitol-hill-report/. 

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses posterior cortical atrophy. To learn more, read the article "Posterior Cortical Atrophy" by Dr. Jonathan M. Schott and Dr. Sebastian J. Crutch in that issue.

Dr. Tamara Pringsheim discusses guideline recommendations on assessment and management of tics in people with Tourette's Syndrome and chronic tic disorders.

New York Times staff writer Pam Belluck discusses the WHO and regulation on human gene editing. Read her March 19, 2019, article here: https://www.nytimes.com/2019/03/19/health/who-panel-demands-a-registry-for-human-gene-editing.html. 

Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome.